ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Jiangsu Aidea Pharmaceutical Group Co., Ltd. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 7 studies whose lead sponsor is Jiangsu Aidea Pharmaceutical Group Co., Ltd. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 18, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Pipeline: 3 programs

Each counted once: 3 with a study Jiangsu Aidea Pharmaceutical Group Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Jiangsu Aidea Pharmaceutical Group Co., Ltd.’s own registered studies; Jiangsu Aidea Pharmaceutical Group Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Jiangsu Aidea Pharmaceutical Group Co., Ltd.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

2 of Jiangsu Aidea Pharmaceutical Group Co., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. 1J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 7 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now229%
  • Under way, not recruiting229%
  • Completed343%

Phase

  • Phase 16
  • Phase 22
  • Phase 31

Where

  • China7

Over the years

  1. 24
  2. 25
  3. 326

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Jiangsu Aidea Pharmaceutical Group Co., Ltd.

  • Jiangsu Aidea Pharmaceutical Group Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies

Studies

Recruiting first, then most recently updated. Showing 7 of 7.